Anna Shteingauz
About Anna Shteingauz
Anna Shteingauz is the Associate Director of Animal Research at Novocure in Israel, with over 8 years of experience at the company.
Company
Anna Shteingauz is currently employed at Novocure, a company specializing in innovative medical device technologies. She has been with the company for over 8 years, demonstrating a strong commitment to her work and the company's mission. Novocure is known for pioneering cancer treatment through tumor-treating fields (TTFields) therapy.
Title
Anna Shteingauz holds the title of Associate Director of Animal Research at Novocure. In this role, she oversees and directs research projects involving animal models to support the development and testing of Novocure's medical technologies.
Background
Anna Shteingauz started her career at Novocure in 2015 as a Researcher. During her tenure, she was promoted to Project Manager in 2017 and then to her current position as Associate Director of Animal Research in 2020. Her career progression at Novocure highlights her expertise and dedication to advancing cancer treatment technologies.
Education and Expertise
Anna Shteingauz earned her Doctor of Philosophy (PhD) in Oncology and Cancer Biology from the Technion - Israel Institute of Technology, which she attended from 2010 to 2014. Her academic background in oncology and cancer biology forms the foundation of her research and development work at Novocure.